The Novitas decision is not all doom and gloom for Pacific Edge

The Novitas decision is not all doom and gloom for Pacific Edge
(Image: Pacific Edge)
Rebecca Howard
News Pacific Edge's Cxbladder tests will no longer be covered by US national health insurance provider Medicare is a “game-changing announcement” but “not all doom and gloom” says Forsyth Barr analysts.On Wednesday, the company confirmed a so-called “local coverage determination” from Novitas – the Medicare administrative contractor – that meant its suite of products does not meet the threshold required for coverage under the US Social Security Act. The stock fell nearly 90% on the news.&...

More Markets

NZX sharemarket flat, up 0.02%
Markets Market Close

NZX sharemarket flat, up 0.02%

The S&P/NZX 50 Index closed at 13,486.32, up 2.3 points or 0.02%.

Tourism Holdings to close Brisbane RV factory, cut 110 roles
Markets

Tourism Holdings to close Brisbane RV factory, cut 110 roles

Tourism Holdings will close its recreational-vehicle manufacturing plant in Brisbane on Dec 19 and consolidate all production at Action Manufacturing in Hamilton after a review of its Australasian operations.The move will cut about 110 frontline and support roles in Australia.Chi...

Property stocks outshine NZX 50 so far in 2025
Finance

Property stocks outshine NZX 50 so far in 2025

But the sector takes a breather in November as reporting season ends.

Thinking of investing? Skip 'most' of NZX
Opinion

Simon Robertson: Thinking of investing? Skip 'most' of NZX

If you want to grow your wealth, then buy the S&P 500. Period.

Simon Robertson 06 Dec 2025